|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018213,
umls-concept:C0020550,
umls-concept:C0025644,
umls-concept:C0033522,
umls-concept:C0040125,
umls-concept:C0087111,
umls-concept:C0178602,
umls-concept:C0206012,
umls-concept:C0239307,
umls-concept:C0443252,
umls-concept:C0544452,
umls-concept:C1257890,
umls-concept:C1274040,
umls-concept:C1280500,
umls-concept:C1521828
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-1-11
|
|
pubmed:abstractText |
The optimal antithyroid drug regimen for Graves' disease remains a matter of controversy. The European Multicentre Trial Group has investigated the effects of methimazole drug dose on the long-term outcome of Graves' disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
451-7
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9876342-Adult,
pubmed-meshheading:9876342-Antithyroid Agents,
pubmed-meshheading:9876342-Drug Administration Schedule,
pubmed-meshheading:9876342-Follow-Up Studies,
pubmed-meshheading:9876342-Graves Disease,
pubmed-meshheading:9876342-Humans,
pubmed-meshheading:9876342-Methimazole,
pubmed-meshheading:9876342-Middle Aged,
pubmed-meshheading:9876342-Prospective Studies,
pubmed-meshheading:9876342-Recurrence,
pubmed-meshheading:9876342-Time Factors,
pubmed-meshheading:9876342-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
|
|
pubmed:affiliation |
Department of Clinical Endocrinology, Medizinsche Klinik und Poliklinik, University of Essen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
